58.94
price up icon0.15%   0.00555
 
loading

Finanzdaten der Bristol Myers Squibb Co-Aktie (BMY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.29%
12,502.00
12,222.00 12,269.00 11,201.00 12,342.00
Cost Of Revenue
19.27%
4,097.00
3,435.00 3,372.00 3,033.00 4,812.00
Gross Profit
4.35%
8,405.00
8,787.00 8,897.00 8,168.00 7,530.00
Operating Expenses
22.25%
6,935.00
5,673.00 7,124.00 5,197.00 7,355.00
Benefits Costs and Expenses
21.12%
11,032.00
9,108.00 10,496.00 8,230.00 12,167.00
Costs And Expenses
21.12%
11,032.00
9,108.00 10,496.00 8,230.00 12,167.00
Operating Income/Loss
52.79%
1,470.00
3,114.00 1,773.00 2,971.00 175.00
Income/Loss Before Equity Method Investments
56.09%
1,370.00
3,120.00 1,810.00 2,980.00 131.00
Income/Loss From Equity Method Investments
1,767%
100.00
-6.00 -37.00 -9.00 8.00
Income/Loss From Continuing Operations Before Tax
52.79%
1,470.00
3,114.00 1,773.00 2,971.00 175.00
Income Tax Expense/Benefit, Deferred
9.19%
-392.00
-359.00 -437.00 223.00 -791.00
Income Tax Expense/Benefit
58.22%
384.00
919.00 460.00 509.00 99.00
Income/Loss From Continuing Operations After Tax
50.52%
1,086.00
2,195.00 1,313.00 2,462.00 76.00
Net Income/Loss
50.57%
1,085.00
2,195.00 1,313.00 2,462.00 76.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
66.67%
-2.00
-6.00 3.00 6.00 4.00
Basic Average Shares
100.00%
-
2,036.00 2,035.00 2,031.00 1.00
Diluted Average Shares
100.00%
-
2,039.00 2,038.00 2,040.00 1.00
Basic Earnings Per Share
50.00%
0.54
1.08 0.64 1.21 0.04
Diluted Earnings Per Share
50.93%
0.53
1.08 0.64 1.20 0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general PFE
$26.68
price down icon 0.69%
drug_manufacturers_general NVO
$37.91
price down icon 0.32%
$147.63
price up icon 1.59%
$371.90
price up icon 0.95%
drug_manufacturers_general MRK
$115.97
price down icon 0.07%
drug_manufacturers_general NVS
$153.57
price down icon 0.50%
Kapitalisierung:     |  Volumen (24h):